Since 2016, we have grown rapidly and many companies have joined the BICO family and the Bio Convergence revolution. Today, we consist of 14 subsidiaries that provide researchers and clinicians with technologies, products and services to create, understand and master biology. Here you can read more about our subsidiaries and how they contribute to our vision – Create the future of health.
By releasing the first universal bioink in 2016, CELLINK democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into the thriving $1 billion industry it is today. CELLINKs bioinks, bioprinters, software and services have enabled critical breakthroughs in a wide range of applications from 3D cell culturing to tissue engineering to drug development.
The world leader of reliable in vitro human tissue model innovation. MatTeks skin, ocular, oral, respiratory, and intestinal tissue models are used to assess safety and efficacy throughout the cosmetics, chemical, pharmaceutical, and household product industries. These advanced tissue models empower companies to achieve their goals of non-animal testing while lowering testing costs and providing human-relevant results.
With over 2,500 users, Nanoscribe develops and produces 3D printers and maskless lithography systems for microfabrication as well as specially developed printing materials and application-specific solution sets. The specialist for additive manufacturing of high-precision structures and objects on the nano-, micro- and mesoscale was founded in 2007 as a spin-off of the Karlsruhe Institute of Technology (KIT).
A pioneer in the field of Digital Light processing (DLP) based printing is an emerging force within the Bioprinting industry. Allegro 3D’s DLP based bioprinting technology enables high-throughput manufacturing of biomedical devices, and precision human tissues for cell culture, drug screening, and regenerative medicine applications.
Founded in 2014, CYTENA deliver automated and highly efficient lab workflows for improved cell line development, microbiome, live cell imaging, liquid handling and omics applications that enable new discoveries in areas such as drug development and health care research. The CYTENA instruments are used in the cell line development workflows at a majority of the worlds top pharmaceutical companies.
Biosero is a San Diego based company, with 75 employees globally and founded in 2003. The company offers software solutions, under the umbrella of Green Button Go, and services which enable seamless laboratory automation for connected and smart workflows.